 |
|
|
|
|
|
|
|
|
|
|
1.
|
Ahnadi, C.E., Pomerleau, J.F, Chapman-Montgomery, S. and Grant, A.M.
Evaluation of the anticoagulants EDTA containing Disodium Diazolidyl Urea to prevent
unsolicited platelet activation. XXth Congress of the International Society on
American Association of Clinical chemistry, Annual meeting, July 15-19, 2007, San Diego, CA, USA.
|
|
2.
|
Ahnadi, C.E., Pomerleau, J.F, Martel, J. and Grant, A.M. Evaluation of the
performance of the TnI-UltraTM Troponin assay on the ADVIA Centaur® CP syste.
Canadian Society of Clinical Chemistry, 51st annual meeting, June 9-13,2007, Toronto, Canada.
|
|
3.
|
Ahnadi, C.E., Pomerleau, J.F, Chapman-Montgomery, S. and Grant, A.M.
Evaluation of the anticoagulants EDTA containing Disodium Diazolidyl Urea to prevent unsolicited platelet activation.
XXIst Congress of the International Society on Thrombosis and Haemostasis (ISTH) July 6 - 12 2007, Geneva, Switzerland.
|
|
4.
|
Ahnadi, C.E., Pomerleau, J.F, Chapman-Montgomery, S. and Grant, A.M.
Effect of the anticoagulants EDTA containing Disodium Diazolidyl Urea on unsolicited platelet activation.
Canadian Society of Clinical Chemistry, 51st annual meeting, June 9-13,2007, Toronto, Canada.
|
|
5.
|
Ahnadi, CE, Pomerleau, JF, Levine, R, Tan, S, Grant, A.
Analytical evaluation of B-type natriuretic peptide (BNP) on the ADVIA IMSÒ 800i system.
American Association of Clinical chemistry, 58td Annual meeting, July 23-27, 2006, Chicago, Illinois, USA. Clinical Chemistry Vol. 42, S.6, pp A122.
|
|
6.
|
Ahnadi, CE, Pomerleau, JF, Levine, R, Tan, S, Grant, A.
Evaluation of the performance of a third-generation TnI-UltraTM assay on the ADVIA IMSÒ 800i system.
American Association of Clinical chemistry, 58td Annual meeting, July 23-27, 2006, Chicago, Illinois, USA. Clinical Chemistry Vol. 42, S.6, pp A122.
|
|
7.
|
Ahnadi, C.E. , Gheorghiu I. , Lepage R. , Beaulieu M., Grant, A. Comparison
of bioavailable testosterone determined by precipitation and calculation using three
automated systems. IFCC/AACC, XIX Annual meeting, July 24-28, 2005, Orlondo,
FL, USA.
|
|
8.
|
Ahnadi CE, Lepage S, Leclair C, Grant A. Marginal effect of interference of
simvastatin on clopidogrel antiplatelet effectiveness assessed by measures of platelet
activation and aggregation. IFCC/AACC, XIX Annual meeting, July 24-28, 2005,
Orlondo, FL, USA.
|
|
9.
|
Ahnadi C. E., Boughrassa F., Chapman S., Poisson V., Gervais A., Okrongly D. and Grant
A. Comparison of two methods to assess variability of platelet response to anti-platelet
therapies in patients with acute coronary syndrome undergoing angioplasty.
Clinical Laboratory 2005, 51:208-209.
|
|
10.
|
Ahnadi, C.E., Boughrassa, F., Chapman, E.S., Okrongly, D., Grant, A.M. Basal
platelet activation and C-reactive protein levels and relationship in patients with
acute coronary syndrome. American Association of Clinical chemistry, 56th
Annual meeting, July 25-29, 2004, Los Angeles, CA, USA.
|
|
11.
|
Gheorghiu, I., Ahnadi, C.E., Lepage R., Hoang, T., and Grant, A.M. Indirect,
automated method for measurement of bioavailable testosterone after precipitation. American
Association of Clinical chemistry, 56th Annual meeting, July 25-29, 2004, Los Angeles,
CA, USA.
|
|
12.
|
Ghani, F, A. Wu, A, Bijou, R, Packer, M, Haverstick, DM, Feldkamp, CS, Thiel, R, Ahnadi,
CE, Mair, J, Johnston , N, Mindicino, H, Conarpe, C. BNP Levels in Heart Failure
for Individuals with Diabetes, Hypertension, COPD, or Renal Disease. American
Association of Clinical chemistry, 56th Annual meeting, July 25-29, 2004, Los Angeles,
CA, USA.
|
|
13.
|
Gheorghiu, I., Ahnadi, C.E., Lepage R., Hoang, T., and Grant, A.M. Measurement
of bioavailable testosterone after precipitation by an indirect, automated method. Canadian
Society of Clinical Chemistry, 48rd annual meeting, June 5-10, 2004, London, ON, Canada.
|
|
14.
|
Ahnadi, C.E., Boughrassa, F., Grant, A.M. Basal platelet activation and C-reactive
protein levels and relationship in patients with acute coronary syndrome. National
Research Forum for Young Investigators in Circulatory and Respiratory Health, May
6-9, 2004, Winnipeg, Manitoba, Canada.
|
|
15.
|
Grant A., Moshyk A., Diab H., Caron P., de Lorenzi F., Desautels M. Integrating
Feedback from a Clinical Datawarehouse into Practice Organisation, Euromise
2004, 12-15 avril 2004, Prague.
|
|
16.
|
Ahnadi, C.E., Boughrassa, F., Chapman, E.S., Okrongly, D., Grant, A.M. Preoperative
platelet activation and c-reactive protein levels and relationship in patients with
acute coronary syndrome. American Society of Hematology, 45th Annual meeting,
December 6-9, 2003, San Diego, CA, USA, Blood, Vol.
|
|
17.
|
Ghani, F, A. Wu, A, Bijou, R, Haverstick, DM, Feldkamp, CS, Thiel, R, Grant, A, Ahnadi,
CE, Mair, J, Despres, N, Mindicino, H, Conarpe, C, Packer, M. Circulating Levels
of B-type Natriuretic Peptide (BNP) are Useful for Diagnosis and are Associated with
Severity of Symptoms in Chronic Heart Failure: Preliminary Data from a Multicenter
Study with Bayer ADVIA Centaur BNP Assay. American Association of Clinical
chemistry, 55th Annual meeting, July 20-24, 2003, Philadelphia, PA, USA. Clinical
Chemistry 2003, Vol. 49, No.6, pp A67.
|
|
18.
|
Gheorghiu, I., Ahnadi, C.E., Lepage R., Hoang, T., and Grant, A.M. An automated
method for the determination of salivary testosterone. American Association
of Clinical chemistry, 55th Annual meeting, July 20-24, 2003, Philadelphia, PA, USA.
Clinical Chemistry 2003, Vol. 49, No.6, pp A131.
|
|
19.
|
Caron, P., Desautels M., de Lorenzi. F, Grant, A., Gestion de l'information
en santé: de la Collection des Données, par sa Gestion vers la Livraison de l'Information. 10e
Journées Francophones d'informatique médicale, Tunis 2003.
|
|
20.
|
Djaider, L, Moshyk, A, Giroux, S, Caron, P , Nguyen M, Grant, A Analyse sur
la mise en place d'un cadre d'application supportant les médecins dans la modélisation
et la résolution de problèmes cliniques. 10e Journées Francophones d'informatique médicale, Tunis 2003
|
|
21.
|
Caron, P., Grant, A., Leblanc, F., Jari, J., Didacticus, a multi dimensional
Online learning environment, IMIA Working Group for Education Conference 2003
Teach Globally, Learn Locally: Innovations in Health and Biomedical Informatics Education
in the 21st Century, Portland, Oregon, USA.
|
|
22.
|
Ahnadi, C.E., Boughrassa, F., Chapman, E.S., Lachance J., Dumont, G., Grant, A.M. Relation
between platelet activation and inflammation in patients with acute coronery syndrome. Canadian
Society of Clinical Chemistry, 47rd annual meeting, June 1-5,2003, Saint-Sauveur,
Qc, Canada.
|
|
23.
|
Gheorghiu, I., Ahnadi, C.E., Lepage R., Hoang, T., and Grant, A.M. Adaptation
of an automated serum testosterone method to saliva. Canadian Society of Clinical
Chemistry, 47rd annual meeting, June 1-5,2003, Saint-Sauveur, Qc, Canada.
|
|
24.
|
Lepage, S., Ahnadi, C.E., Lucena-Fernandes, F., Kelly, A. , Grant, A. Role of
Cardiac Markers in Patients with Unstable Angina at Intermediate Risk. Canadian
Cardiovascular Congress 2002, October 26-30, 2002, Edmonton, Alberta, Canada.
|
|
25.
|
Benchakroun, A., Caron, P., Dion, J-G, A One-dimensional Cutting Stock Problem:
Exact and approximate solutions for the global problem, CIRO'02, Marrakech
2002.
|
|
26.
|
Caron, P., Benchakroun, A., Dion, J-G, A One-dimensional Cutting Stock Problem:
Exact algorithms for minimising the total loss and the number of set-ups,
JOPT 02, Montral 2002.
|
|
27.
|
Caron, P., Benchakroun, A., Dion, J-G, A One-dimensional Cutting Stock Problem
: Exact and approximate solutions for the knife's moves problem, JOPT 02,
Montral 2002.
|
|
28.
|
Ahnadi, C.E., Boughrassa, F., Chapman, E.S., Poisson V., Gervais A., Lépine M., Lachance
J. Dumont, G., Grant, A.M. Monitoring the effect of anti-platelet agents on
the platelet count and function using the automated ADVIA120 Hematology System.
American Association of Clinical chemistry, 54rd Annual meeting, July 28-August 1,
2002, Orlando, Florida, USA. Clinical Chemistry Vol. 48, No.6, pp A112.
|
|
29.
|
Ahnadi, C.E., Sabourin A., Langlois M.F. , Lachance, J.F., Dumont G., Lepage R. ,
Grant, A.M. Biological day-to-day variation of salivary and serum cortisol in
healthy donors. American Association of Clinical chemistry, 54rd Annual meeting,
July 28-August 1, 2002, Orlando, Florida, USA. Clinical Chemistry Vol. 48, No.6, pp
A136.
|
|
30.
|
Ahnadi, C.E., Lachance, J.F., Dumont, G., Dillon, P.W., Tan, S., Readio, J., Barbarakis,
M., Grant, A.M. Clinical evaluation of Vancomycin and Theophylline 2 on the
ADVIA Centaur and ACS:180 systems. American Association of Clinical chemistry,
54rd Annual meeting, July 28-August 1, 2002, Orlando, Florida, USA. Clinical Chemistry
Vol. 48, No.6, pp A51.
|
|
31.
|
Ahnadi, C.E., Lachance, J.F., Dumont, G., Saxton, C., Grant, A.M. Clinical Evaluation
of the CA 15-3 Assay on the ADVIA Centaur System. American Association of
Clinical chemistry, 54rd Annual meeting, July 28-August 1, 2002, Orlando, Florida,
USA. Clinical Chemistry Vol. 48, No.6, pp A27.
|
|
32.
|
Ahnadi, C.E., Boughrassa, F., Chapman, E.S., Lachance J., Dumont, G., Grant, A.M. Platelet
activation variability in patient response to Clopidogrel and abciximab. International
Society of Animal Clinical Biochemistry, June 18-22, 2002, Gainesville, Florida, USA.
|
|
33.
|
Ahnadi, C.E., Boughrassa, F., Poisson V., Chapman, E.S., Gervais A., Lépine M., Lachance J., Dumont, G., Grant, A.M. Monitoring the Effect of anti-platelet agents on the Platelet count using the automated ADVIA120 Hematology System. American
Society of Hematology, 43rd Annual meeting,December 7-11, 2001, Orlando, Florida,
USA, Blood, Vol 98, number 11, 2001, p254a.
|
|
34.
|
Ahnadi, C.E., Boughrassa, F., Poisson V., Chapman, E.S., Gervais A., Lépine M., Lachance J., Dumont, G., Grant, A.M. Platelet activation variability in Patient response to Abciximab and clopidogrel. Blood, Vol 98, number 11, 2001, p254a.
|
|
35.
|
Ahnadi, C.E., Poisson V., Chapman, E.S., Gervais A., Lépine M., Boughrassa, F., Lachance J., Dumont, G., Grant, A.M. Evaluation of platelet activation for monitoring the anti-platelet effects of Clopidogrel and ReoPro. American Association of Clinical chemistry, 53rd Annual meeting, July 26-August 2, 2001, Chicago, Illinois, USA. Clinical Chemistry Vol. 47, No.6, pp A173.
|
|
36.
|
Lepage, S., Ahnadi, C.E., Lucena-Fernandes, F., Kelly, A. , Armstrong, G. , Ghani,
F., Grant, A. Role of cardiac markers in patients with unstable angina at intermediate risk. American Association of Clinical chemistry, 53rd Annual meeting, July 26-August 2, 2001, Chicago, Illinois, USA. Clinical Chemistry Vol. 47, No.6, pp A214.
|
|
37.
|
Ahnadi, C.E., Poisson V., Chapman, E.S., Gervais A., Lépine M., Boughrassa, F., Lachance J., Dumont, G., Grant, A.M. Platelet activation evaluation for anti-platelet therapy monitoring using the automated ADVIA 120 Hematology System. International Society on Thrombosis and Haemostasis, July 6-12, 2001, Paris, France.
|
|
38.
|
Benchakroun, A., Caron, P., Dion, J-G, Exact Algorithms for the Global One-dimensional Cutting problem, Optimization 2001, Aveiro, juillet 2001.
|
|
39.
|
Caron, P., Benchakroun, A., Dion, J-G, Algorithmes efficaces pour la résolution exacte du problème global de coupe unidimensionnelle, SCRO-JOPT, Québec, mai 2001.
|
|
40.
|
Lepage, S., Ahnadi, C.E., Lucena-Fernandes, F., Kelly, A. , Armstrong, G. , Ghani,
F., Kaplan, I., Grant, A. Performance of cardiac markers and ECG in relation
to the Braunwald classification of unstable angina. Clinical Ligand Assay
Society,27th meeting, May 16-19, 2001, Detroit, MI, USA.
|
|
41.
|
Boughrassa F.F., Ahnadi C.E., Poisson V., Chapman E.S., Grant A.M. Comparaison
de l'effet de différents anticoagulants sur l'activation des plaquettes in vitro. Club de Recherche Clinique. 42ème réunion annuelle. Septembre 2000. Bromont, Qc, Canada.
|
|
42.
|
Amar Bensaber B, Couture L, Tremblay N, Drapeau D, Blanchette D, Arsenault S, Maheux
P, Gagné C, Gaudet D, Grant A.M. PIERCE : Prototypage Informatique en Recherche Clinique. Club de Recherche Clinique. 42ème réunion annuelle. Septembre 2000.
Bromont, Qc, Canada
|
|
43.
|
Leblanc F, Grant A.M et al. Implémentation des lignes directrices cliniques
- Facteurs influençant la vitesse d'introduction d'un nouveau test diagnostique. Club de Recherche Clinique. 42ème réunion annuelle. Septembre 2000. Bromont, Qc, Canada.
|
|
44.
|
Bolduc L, Grant A.M et al. Amélioration de l'évidence et des mécanismes de pro-action et de rétroaction dans le développement de nouvelles technologies de diagnostic en biomédecine. Club de Recherche Clinique. 42ème réunion annuelle. Septembre 2000. Bromont, Qc, Canada.
|
|
45.
|
Ahnadi C.E., Chapman E.S., Hoang T., Lucena-Fernandes F., and Grant A.M. Evaluation
of platelet activation in patient with chest pain by the Advia 120 hematology system. American Association of Clinical chemistry. 52nd Annual meeting, July 23-27, 2000,
San Fransisco, CA, USA.
|
|
46.
|
Ahnadi C.E., Lachance J.F., Préville M., Martel J., Grant A.M. Effective adaptation
of an available automated method for serum cortisol in order to measure salivary cortisol.
American Association of Clinical chemistry, 52nd Annual meeting, July 23-27,
2000, San Fransisco, CA, USA.
|
|
47.
|
Lucena-Fernandes F., Lepage S., Kelly A., Armstrong G., Ahnadi C., Lachance J.F.,
Grant A.M. Correlation of Troponin I, Troponin T, CK-MB, ECG and Severity of
Unstable Angina. American Association of Clinical chemistry. 52nd Annual meeting, July 23-27, 2000, San Fransisco, CA, USA.
|
|
48.
|
Ahnadi C.E., Chapman E.S., Okrongly D., Hoang T., Lucena-Fernandes F., and Grant A.M. Evaluation of Platelet Activation in Patients with Chest Pain by the ADVIA 120 Hematology System. The Fifth International Bayer Diagnostics Laboratory Symposium, June 25-27, 2000, Seville, Spain.
|
|
49.
|
Amar Bensaber B., Couture L., Tremblay N., Drapeau D., Blanchette D., Arsenault S.,
Maheux P., Gagné C., Gaudet D., et Grant A.M. PIERCE Programme: Informatics
Support for Multisite Clinical Research. Infocus 2000, Vancouver, British
Columbia, Canada.
|
|
50.
|
Lucena-Fernandes F., Lepage S., Kelly A., Armstrong G., Ahnadi C., Lachance J.F.,
Grant A.M. Correlation of Troponin I, Troponin T, CK-MB, ECG and Severity of
Unstable Angina. 44th Annual CSCC-CAMB-AACC conference, June 3-7,
2000, Hamilton, Ontario, Canada.
|
|
51.
|
Ahnadi C.E., Lachance J.F., Préville M., Martel J., Grant A.M. Effective adaptation of an available automated method for serum cortisol in order to measure salivary cortisol. 44th Annual CSCC-CAMB-AACC conference, June 3-7, 2000, Hamilton, Ontario, Canada.
|
|
52.
|
Amar Bensaber B., Couture L., Tremblay N., Drapeau D., Blanchette D., Arsenault S.,
Maheux P., Gagné C., Gaudet D., et Grant A.M. PIERCE : Prototypage Informatique en Recherche Clinique. 8e Journées Francophones d'Informatique Médicale, 30-31 mai 2000, Marseille, France.
|
|
53.
|
Ahnadi C.E., Chapman E.S., Hoang T., Lucena-Fernandes F., and Grant A.M. Evaluation
of platelet activation in patient with chest pain. 9th Arab congress
of Clinical Biology & International Federation of Clinical Chemistry and Laboratory
Medicine. May 3-6, 2000, Rabat, Morocco.
|
|
54.
|
Ahnadi C.E. Potential use of new parameters of Platelet activation in clinical
applications. XIIIth International Symposium on Technological Innovations in Laboratory Hematology, April 12-16, 2000, Banff, Canada - Invited Speaker, 2000.
|
|
55.
|
Ahnadi C.E., Chapman E.S., Hoang T., Lucena-Fernandes F., and Grant A.M. Evaluation
of platelet activation in patient with chest pain by the Advia 120 hematology system. XIIIth International Symposium on Technological Innovations in Laboratory Hematology, April 12-16, 2000, Banff, Canada.
|
|
56.
|
Grant A.M. Clinicians use of report cards and information for accountability
: mixing mismatched expectations. HEALNet Network of Centres of Excellence
Annual Meeting - Invited Speaker, 2000.
|
|
57.
|
Massé M., Ahnadi C.E., Gagné E.R., Dufresne J., Letendre S., Grant A. Estblishment of characteristics reticulocyte hemoglobin content (CHr) reference ranges and comparison of two IV maintenance iron regimes in hemodialysis patients. Meeting of the Canadian Society of Nephrology, March 2000, Montreal, Canada.
|
|
58.
|
Amar Bensaber B., Couture L., Tremblay N., Drapeau D., Blanchette D., Arsenault S.,
Maheux P., Gagné C., Gaudet D., et Grant A.M. PIERCE : Prototypage Informatique en Recherche Clinique. 2eè Colloque sur l'informatique appliquée à la recherche biomédicale et clinique, 2-3 mars 2000, Sherbrooke, Québec.
|
|
59.
|
Poisson V., Boughrassa F., Amar Bensaber B., Hoang T., Lachance J.F., Ahnadi C.E.,
Grant A.M. Utilité d'un site web dans la recherche évaluative multisite. 2è Colloque sur l'informatique appliquée à la recherche biomédicale et clinique, 2-3 mars 2000, Sherbrooke, Québec.
|
|
60.
|
Ahnadi C.E., Masse M., Gagné E., Dufresne J.F., Letendre S., Lachance J., Grant A.M. Reticulocyte hemoglobin content as a sensitive marker of functional iron deficiency in hemodialysis patients: establishment of characteristic CHr reference ranges and comparison of two low-dose intravenous maintenance iron regimes. American Society of Nephrology, 32nd Annual meeting, November 5-8,1999.
|
|
61.
|
Masse M., Ahnadi C.E., Langlois N., Letendre S., Gagné E.-R., Dufresne, J., Lachance J.F., Langley R., Grant A.M. Étude comparant deux modalités d'administration de petites doses de fer Dextran en thérapie de maintenance chez les patients hémodialysés chroniques. Mesure des différents paramètres de suivi des réserves de fer et d'un nouveau marqueur (CHr) contenu en hémoglobine réticulocytaire comme marqueur de la
déficience fonctionnelle en fer. Société de Néphrologie et Société Francophone de Dialyse, 6-8 octobre 1999, Lausanne, Suisse.
|
|
62.
|
Ahnadi C.E., Lépine M., Lambert G., Chapman E.S. and Grant A.M. Comparison of
in vitro platelet activation in blood collected into sodium citrate, EDTA or Diatube-H.,
American Association of Clinical chemistry. 51st Annual meeting,
July 25-29,1999, New Orleans, Louisiana, USA. Clinical Chemistry Vol. 45, No.6, pp
A60.
|
|
63.
|
Ahnadi C.E., Lachance J.F., Fink G., Grant A.M. Third Generation TSH assay performance on the Bayer Immuno 1 system, International Federation of Clinical chemistry and Laboratory Medicine. 1999 annual meeting, June 6-11, Firenze, Italy. Clinical chemistry and Laboratory Medicine Vol.37, pp 171.
|
|
64.
|
Ahnadi C.E., Lépine M., Lambert G., Chapman E.S. and Grant A.M. Comparison of
in vitro platelet activation in blood collected into sodium citrate vs CTAD.
International Federation of Clinical chemistry and Laboratory Medicine, 1999 annual
meeting, June 6-11, Firenze, Italy. Clinical chemistry and Laboratory Medicine Vol.37,
pp 200.
|
|
65.
|
Ahnadi C.E., Lachance J.F., Fink G. and Grant A.M. Third Generation TSH assay
performance on the Bayer Immuno 1 system. Canadian Society of
Clinical Chemistry, 43rd annual meeting, May 8-13,1999,Winnepeg, Alberta
Canada.
|
|
66.
|
Ahnadi C.E., Lepine M., Lambert G., Chapman E.S. and Grant A.M. Effects of sodium
citrate and CTAD anticoagulants on platelet activation in vitro. Canadian
Society of Clinical Chemistry, 43rd annual meeting, May 8-13,1999,Winnepeg,
Alberta Canada.
|
|
67.
|
Martel J., Després N., Lachance J.-F., Dillon P.W., Grant A.M. Evaluation of
the Procainamide Assay on the Bayer Immuno 1 System. American Association
for Clinical Chemistry & Canadian Society of Clinical Chemists. 1998 Annual
Meeting, August 4-6, Chicago, IL.
|
|
68.
|
Després N., Martel J, Lachance J.-F., Fink G.D., Monticello J., Grant A.M. Evaluation of the Analytical Performance of the Bayer Immuno 1® and Chiron ACS:180® Thyroid Panels. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists. 1998 Annual Meeting, August 4-6, Chicago, IL.
|
|
69.
|
Martel J., Després N., Lachance J.-F., Dillon P.W., Grant A.M. Evaluation of
the N-Acetylprocainamide (NAPA) Assay on the Bayer Immuno 1® System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 1998 Annual Meeting, August 4-6, Chicago, IL.
|
|
70.
|
Martel J., Després N., Dillon P.W., Carpenter W., Grant A.M. Evaluation of the CA 72-4 Assay on the Bayer Immuno 1 System. American Association
for Clinical Chemistry & Canadian Society of Clinical Chemists. 1998 Annual Meeting,
August 4-6, Chicago, IL.
|
|
71.
|
Martel J., Després N., Lachance J.-F., Fink G.D., Monticello J.E., Grant A.M. Evaluation of the Analytical Performance of the Bayer Immuno 1 and Chiron ACS:180 Thyroid Panels. Canadian Society of Clinical Chemists & Canadian Association of Medical Biochemists, Annual Meeting, Ottawa, June 14-18, 1998.
|
|
72.
|
Martel J., Després N., Lachance J.-F., Dillon P.W., Grant A.M. Evaluation of
the Procainamide Assay on the Bayer Immuno 1 System. Canadian
Society of Clinical Chemists & Canadian Association of Medical Biochemists, Annual
Meeting, Ottawa, June 14-18, 1998.
|
|
73.
|
Martel J., Després N., Lachance J.-F., Dillon P.W., Grant A.M. Evaluation of
the N-Acetylprocainamide (NAPA) Assay on the Bayer Immuno 1 System.
Canadian Society of Clinical Chemists & Canadian Association of Medical Biochemists,
Annual Meeting, Ottawa, June 14-18, 1998.
|
|
74.
|
Xhignesse M., Laplante P., Niyonsenga T., Delisle E., Vanasse N., Grant A.M, Bernier
R. Physician knowledge of patient lipoprotein profiles : Analysis of the FAMUS
database. 4th International Conference on Preventive Cardiology.
Montréal, Québec, 29 juin au 3 juillet 1997. Can J. Cardiol Vol 13 Suppl B June 1997, p. 292B.
|
|
75.
|
Xhignesse M., Grant A.M, Laplante P., Niyonsenga T., Delisle E., Charlin B., Grand'Maison
P. From FAMUS to PRIMUS : Review of a five year network experience and future
orientations. 1997 ACTH-CAME Annual Meeting. Halifax, Nova Scotia, 3-7 mai
1997.
|
|
76.
|
Niyonsenga T., Xhignesse M., Vanasse N., Laplante P., Grant A.M. Time related
practice variation : Effects of physician interventions on some cardiovascular disease
risk factors. 1997 CDC and ATSDR Symposium on Statistical Methods, Atlanta,
Georgia, 29-30 janvier 1997.
|
|
77.
|
Xhignesse M., Laplante P., Niyonsenga T., Delisle E., Vanasse N., Bernier R., Grant
A.M. Secondary prevention of CVD : Are we doing enough? Analysis of the FAMUS
database. 25e Assemblée annuelle de NAPCRG. Orlando, Floride, USA. 12 au 15
novembre 1997.
|
|
78.
|
Laplante P., Xhignesse M., Niyonsenga T., Delisle E., Grant A.M., Vanasse N. Traitement en monothérapie de l'hypertension non compliquée par un groupe d'omnipraticiens du Québec. Données du registre provincial FAMUS. 1er Colloque du réseau FRSQ sur l'utilisation des médicaments. Montréal, Québec, 16-17 juin 1997.
|
|
79.
|
Laplante P., Xhignesse M., Niyonsenga T., Delisle E., Grant A.M., Vanasse N. Traitement en monothérapie de l'hypertension non compliquée par un groupe d'omnipraticiens du Québec. Données du registre provincial FAMUS, 9e Journée québécoise de la recherche en médecine familiale. Montréal, Québec, 13 juin 1997.
|
|
80.
|
Laplante P., Niyonsenga T., Delisle E., Vanasse N., Bernier R., Grant A.M., Xhignesse
M. Treatment of dyslipidemias : Five years of Evolution in the FAMUS Network. Conférence 97 Société canadienne d'épidémiologie et de biostatistiques. London, Ontario,
25-28 mai 1997.
|
|
81.
|
Richard Y., Dagenais A., Buteau M., Deland E., Gauthier S., Mehta V., Grant A.M. The
use of an executive information system tool in interaction with the electronic medical
record as a source of dynamic feedback for the clinical professional - a study forming
part of the Autocontrol Project. HEALNet Annual General Meetings, November
13-15, Toronto, Ontario, 1997.
|
|
82.
|
Gauthier S., Richard Y., Mehta V., Deland E., de Lorenzi F., Veilleux M., Buteau M.,
Grant A.M. Examining the use of internal and external evidence in the process
of decision making for a change in the practice of use of blood gases in the surgical
intensive care unit - a study forming part of the Autocontrol Project. HEALNet
Annual General Meetings, November 13-15, Toronto, Ontario, 1997.
|
|
83.
|
Mehta V., Kushniruk A., Gauthier S., Richard Y., Deland E., Veilleux M., Patel V.,
Grant A.M. The efficient use of information by the professional team of a clinical
unit to obtain consensus for practice change - a study forming part of the Autocontrol
Project. HEALNet Annual General Meetings, November 13-15, Toronto, Ontario,
1997.
|
|
84.
|
Grant A.M., Richard Y., Deland E., Després N., Buteau M. Involving Clinicians
in Managerial Decision Making Annual Meeting CAME, Halifax, May 3-7, 1997.
|
|
85.
|
Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Quinidine
Assay on the Bayer Technicon Immuno 1 System. 41st Annual
Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.
|
|
86.
|
Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Carbamazepine Assay on the Bayer Technicon Immuno 1 System. 41st Annual Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.
|
|
87.
|
Martel J., Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the
Valproic Acid Assay on the Bayer Technicon Immuno 1 System. 41st Annual Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.
|
|
88.
|
Martel J., Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the
Vancomycin Assay on the Bayer Technicon Immuno 1 System. 41st Annual Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.
|
|
89.
|
Richard Y., Buteau M., Deland E., Després N., Grant A.M. Autocontrol for Optimizing Test Use - A Partnership Between Laboratory Professionals and Clinical Decision Makers. 41st Annual Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.
|
|
90.
|
Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Quinidine
Assay on the Bayer Technicon Immuno 1 System. American Association for
Clinical Chemistry. 49th Annual Meeting, 20-24 July 1997, Atlanta,
GA. Clin Chem 1997;43:S208.
|
|
91.
|
Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Carbamazepine Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry, 49th Annual Meeting, Atlanta, GA, 20-24 July. Clin Chem 1997;43:S208.
|
|
92.
|
Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Valproic Acid Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry, 49th Annual Meeting, Atlanta, GA, 20-24 July. Clin Chem 1997;43:S208.
|
|
93.
|
Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Vancomycin
Assay on the Bayer Technicon Immuno 1 System. American Association
for Clinical Chemistry, 49th Annual Meeting, Atlanta, GA, 20-24 July. Clin
Chem 1997;43:S208.
|
|
94.
|
Xhignesse M., Niyonsenga T., Delisle E., Vanasse N., Laplante P., Grant A.M., Bernier
R. Cardiovascular risk and the use of hormone replacement therapy by women 55
years of age and over : Analysis of the FAMUS primary care register. 11e réunion du Réseau canadien de santé du coeur, Calgary Alberta, 23-25 mai 1996.
|
|
95.
|
Xhignesse M., Niyonsenga T., Delisle E., Vanasse N., Laplante P., Grant A.M., Bernier
R. Cardiovascular disease and the use of hypolipidemic agents in individuals
65 years of age or over : Analysis of the FAMUS primary care register. 11e réunion du Réseau canadien de santé du coeur, Calgary, Alberta, 23-25 mai 1996.
|
|
96.
|
Grant A.M, Xhignesse M., Buteau M., Oumar B.A., Richard Y., Després N., Léonard K. Methodologies for evaluation research in the clinical setting. 1996 International health evaluation association. Victoria, British Columbia, 9-12 octobre 1996.
|
|
97.
|
Laplante P., Vanasse A., Xhignesse M., Grant A.M., Bernier R. Observance des
médecins de famille au Consensus canadien sur l'hypertension face à la notation de
la tension artérielle. Présentation orale, 8e Journée de la recherche en médecine familiale. Sherbrooke, Québec, 10-14 juin 1996.
|
|
98.
|
Xhignesse M., Niyonsenga T., Delisle E., Vanasse N., Laplante P., Grant A.M., Bernier
R. Prévalence de l'hormonothérapie de remplacement chez les femmes âgées de 55 ans ou plus selon le registre FAMUS. Présentation par affiche, 8e Journée de la recherche en médecine familiale. Sherbrooke, Québec, 10-14 juin 1996.
|
|
99.
|
Xhignesse M., Niyonsenga T., Delisle E., Vanasse N., Laplante P., Grant A.M., Bernier
R. Maladies cardiovasculaires et utilisation des agents hypolipidémiants chez
les individus âgés de 65 ans et plus : une analyse du registre de soins primaires FAMUS. Présentation orale, 12e Congrès de la Société québécoise de gériatrie Québec, Québec, 30 mai au 1er juin 1996.
|
|
100.
|
Lévesque A., Letellier M., Grant A.M. évaluation analytique de l'essai pour le dosage de la testostérone totale sur l'autoanalyseur Technicon Immuno 1 de Bayer. SQBC Annual Meeting, September 11-14, 1996.
|
|
101.
|
Fortin C., Després N., Letellier M., Grant A.M. élévation non-spécifique de la thyroxine libre en présence d'autoanticorps anti-thyroxine. SQBC Annual Meeting, September 11-14, 1996.
|
|
102.
|
Letellier M., Lévesque A., Daigle F., Grant A.M. Performance Evaluation of Automated Immunoassays on the Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S142.
|
|
103.
|
Letellier M., Lévesque A., Dillon P.W., Grant A.M. Determination of the Reference Ranges for FSH, LH, Estradiol and Progesterone in Normal Cycling Females on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S233.
|
|
104.
|
Lévesque A., Letellier M., Dillon P.W., Grant A.M. Evaluation of the Estradiol Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S232.
|
|
105.
|
Lévesque A., Letellier M., Dillon P.W., Grant, A.M. Evaluation of the Progesterone Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S232.
|
|
106.
|
Després N., Hartl F.T., Letellier M., Lévesque A., Grant A.M. Evaluation of the Serum Folate Assay on the Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S126.
|
|
107.
|
Després N., Mattes-Pound M.L., Letellier M., Grant A.M. Evaluation of the Red
Blood Cell Folate Assay on the Technicon Immuno 1 System. American
Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S125.
|
|
108.
|
Després N., Fortin C., Letellier M., Grant A.M. Spuriously High Concentration
of Serum Free Thyroxine Due to Anti-Thyroxine Autoantibodies. American Association
for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual
Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S311.
|
|
109.
|
Xhignesse M., Grant A.M., Delisle E., Niyonsenga T., Laplante P., Bernier R. Le
projet FAMUS : Un registre de soins primaires québécois pour les facteurs de risque des maladies cardiovasculaires. Présentation orale, 7e Journée de la recherche en médecine familiale. Montréal, 24 avril 1995.
|
|
110.
|
Xhignesse M., Niyonsenga T., Delisle E., Laplante P., Grant A.M., Bernier R. Intervention des médecins et cessation du tabac : analyse des données du registre FAMUS. Présentation orale, 7e Journée de la recherche en médecine familiale. Montréal, 24 avril 1995.
|
|
111.
|
Xhignesse M., Niyonsenga T., Delisle E., Laplante P., Grant A.M., Bernier R. Physician interventions with respect to their smoking patients : analysis of data from the FAMUS register. Présentation par affiche, 37th Annual Scientific Assembly of the College of Family Physicians of Canada. Québec, Québec, 12-13 mai 1995.
|
|
112.
|
Laplante P., Vanasse A., Xhignesse M., Delisle E., Grant A.M., Bernier R. Monotherapy for hypertention : a cross-sectional analysis from the FAMUS provincial register. Présentation orale, Trillium Primary Care Research Forum. University of Western Ontario, London, Ontario, 27 mai 1995.
|
|
113.
|
Xhignesse M., Grant A.M., Delisle E., Niyonsenga T., Bernier R. Use of a primary
care register for cardiovascular risk factors and disease. Acceptée pour une présentation orale, 2nd International Heart Health Conference. Barcelone, Espagne, 28 mai au 1er juin 1995.
|
|
114.
|
Niyonsenga T., Xhignesse M., Grant A.M., Delisle E. Applications of canonical
ordination methods to epidemiological studies. Présentation orale, Canadian
Society for Epidemiology and Biostatistics. St. John's, Newfoundland, 16-18 août 1995.
|
|
115.
|
Letellier M., Lévesque A., Daigle F., Grant A.M. évaluation de l'autoanalyseur Immuno 1 de Bayer Inc. SQBC Meeting, October 11-14, 1995.
|
|
116.
|
Lévesque A, Letellier M, Grant A.M. évaluation analytique des méthodes progestérone et estradiol sur l'autoanalyseur Immuno 1. SQBC Meeting, October 11-14, 1995.
|
|
|
|
|
|
|
